![](https://worldmedicinefoundation.com/wp-content/uploads/sites/21/2018/12/hlEkZEkoAFOdOleNHWuK.jpg)
![](https://worldmedicinefoundation.com/wp-content/uploads/sites/21/2018/12/hlEkZEkoAFOdOleNHWuK.jpg)
![](https://worldmedicinefoundation.com/wp-content/uploads/sites/21/2018/12/ORyNFoasaSpDLBEaHRyX.jpg)
Aspirin may help some breast cancer survivors, but changes in DNA may mean harm for others: Chemical changes in DNA — called methylation — in blood and breast cancer tumors may modify aspirin’s role in mortality risk
![](https://worldmedicinefoundation.com/wp-content/uploads/sites/21/2018/12/ORyNFoasaSpDLBEaHRyX.jpg)
Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors: Novel technology based on epigenetic alterations could shorten wait for a definitive diagnosis in resource-poor settings
![](https://worldmedicinefoundation.com/wp-content/uploads/sites/21/2018/12/hlEkZEkoAFOdOleNHWuK.jpg)
Targeting old bottleneck reveals new anticancer drug strategy: Hot target SIRT2 regulates ribonucleotide reductase
![](https://worldmedicinefoundation.com/wp-content/uploads/sites/21/2018/12/ldqgPICAEzXOIOQlNMyG.jpg)